Persistent luminescence nanoparticles excitable in situ for in vivo optical imaging, in vivo multimodal optical—MRI imaging, and theranostics
US9877653B2 · kind B2 · utility
1Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2013 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Apr 30, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC01P2006/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Multimodal optical and magnetic resonance imaging methods based on the use of persistent luminescence nanoparticles. Use of mesoporous persistent luminescence <<core-shell>> complexes for theranostic applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.